Timothy Coughlin's Net Worth
$28.8 Million
Who is Timothy Coughlin?
Timothy Coughlin has an estimated net worth of $28.8 Million. This is based on reported shares across multiple companies, which include NEUROCRINE BIOSCIENCES INC, Travere Therapeutics, Inc., FATE THERAPEUTICS INC, and aTYR PHARMA INC.
SEC CIK
Timothy Coughlin's CIK is 0001376043
Past Insider Trading and Trends
2014 was Timothy Coughlin's most active year for acquiring shares with 16 total transactions. Timothy Coughlin's most active month to acquire stocks was the month of April. 2015 was Timothy Coughlin's most active year for disposing of shares, totalling 14 transactions. Timothy Coughlin's most active month to dispose stocks was the month of January. 2015 saw Timothy Coughlin paying a total of $3,154,500.00 for 312,000 shares, this is the most they've acquired in one year. In 2015 Timothy Coughlin cashed out on 328,500 shares for a total of $8,670,265.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NEUROCRINE BIOSCIENCES INC (NBIX) Snapshot price: $120.17
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.69% | -963.00 |
$43.14 | -$41,543.82 | 137.96K |
Scheduled
|
Feb 6
| ||
Form 4
| -1.09% | -1.50K |
$42.55 | -$63,825.00 | 136.32K |
Scheduled
|
Feb 3
| ||
Form 4
| -1.28% | -1.75K |
$40.65 | -$71,137.50 | 134.82K |
Scheduled
|
Jan 17
| ||
Form 4
| -1.30% | -1.75K |
$43.37 | -$75,897.50 | 133.12K |
Scheduled
|
Jan 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
| -1.13% | -1.50K |
$38.06 | -$57,090.00 | 131.37K |
Scheduled
|
Feb 3
| ||
Form 4
| -1.33% | -1.75K |
$46.69 | -$81,707.50 | 129.87K |
Scheduled
|
Jan 19
| ||
Form 4
| -1.35% | -1.75K |
$44.25 | -$77,437.50 | 128.12K |
Scheduled
|
Jan 11
| ||
Form 4
| -16.52% | -25.00K |
$47.78 | -$1,194,500.00 | 126.37K |
Scheduled
|
Oct 16
| ||
Form 4
|
—
|
0
|
$30.38 | -$984,800.00 | 101.37K |
Scheduled
|
Jul 20
| ||
Form 4
|
—
|
0
|
$27.88 | -$884,800.00 | 101.37K |
Scheduled
|
Jul 13
| ||
Form 4
|
—
|
0
|
$23.84 | -$2,549,400.00 | 101.37K |
Scheduled
|
Jun 8
| ||
Form 4
|
—
|
0
|
$23.54 | -$1,676,000.00 | 101.37K |
Scheduled
|
Mar 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| -1.70% | -1.75K |
$30.81 | -$53,917.50 | 101.37K |
Scheduled
|
Jan 16
| ||
Form 4
| -1.73% | -1.75K |
$28.37 | -$49,647.50 | 99.62K |
Scheduled
|
Jan 12
| ||
Form 4
|
—
|
0
|
$14.92 | -$246,600.00 | 97.87K |
Scheduled
|
Jan 8
| ||
Form 4
|
—
|
0
|
$13.03 | -$626,100.00 | 97.87K |
Scheduled
|
Dec 18 - Dec 19
| ||
Form 4
|
—
|
0
|
$12.67 | -$352,400.00 | 97.87K |
Scheduled
|
Dec 10
| ||
Form 4
| -9.27% | -10.00K |
$20.14 | -$201,400.00 | 97.87K |
Scheduled
|
Nov 28
| ||
Form 4
| -9.27% | -10.00K |
$19.00 | -$190,000.00 | 97.87K |
Scheduled
|
Oct 31
| ||
Form 4
| -9.27% | -20.00K |
$18.31 | -$366,200.00 | 195.75K |
Scheduled
|
Oct 28 - Oct 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
| -1.76% | -1.75K |
$18.56 | -$32,480.00 | 97.87K |
Scheduled
|
Jan 10
| ||
Form 4
| -42.14% | -70.00K |
$16.75 | -$1,172,500.00 | 96.12K |
Scheduled
|
Jan 7
| ||
Form 4
| -16.53% | -19.04K |
$15.05 | -$286,476.75 | 96.12K |
Scheduled
|
Aug 21
| ||
Form 4
| -10.24% | -10.96K |
$14.99 | -$164,365.35 | 96.12K |
Scheduled
|
Aug 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 25
| |||
Form 4
| -11.36% | -12.32K |
$6.83 | -$84,103.71 | 96.12K |
Scheduled
|
Feb 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
| -14.41% | -12.65K |
$2.53 | -$31,971.61 | 75.11K |
Scheduled
|
Mar 1
| ||
Form 4
| -13.78% | -8.70K |
$2.52 | -$21,951.23 | 54.43K |
Scheduled
|
Jan 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 28
| |||
Form 4
| -21.67% | -12.12K |
$3.43 | -$41,537.08 | 43.79K |
Scheduled
|
Mar 30
| ||
Form 4
| -27.27% | -8.46K |
$3.39 | -$28,648.10 | 22.57K |
Scheduled
|
Jan 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
| -15.03% | -7.86K |
$5.02 | -$39,450.29 | 44.41K |
Scheduled
|
Feb 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Travere Therapeutics, Inc. (TVTX) Snapshot price: $10.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +15.29% | 6.5K |
—
|
—
| 49K |
May 8
| |||
Form 4
| +11.84% | 4.5K |
—
|
—
| 42.5K |
May 17
| |||
Form 4
| +8.57% | 3K |
—
|
—
| 38K |
May 11
| |||
Form 4
| +9.38% | 3K |
—
|
—
| 35K |
May 14
| |||
Form 4
| +10.34% | 3K |
—
|
—
| 32K |
May 15
| |||
Form 4
| +7.41% | 2K |
—
|
—
| 29K |
May 8
| |||
Form 4
| +10.20% | 2.5K |
—
|
—
| 27K |
May 9
| |||
Form 4
| +11.36% | 2.5K |
—
|
—
| 24.5K |
May 17
| |||
Form 4
| +10.00% | 2K |
—
|
—
| 22K |
May 18
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FATE THERAPEUTICS INC (FATE) Snapshot price: $3.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +696.46% | 8.65K |
—
|
—
| 9.89K |
Jun 9
| |||
Form 4
| -2.44% | -1.44K |
$22.81 | -$32,823.59 | 57.63K |
Jun 3
| |||
Form 4
| +4.75% | 2.68K |
—
|
—
| 59.07K |
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
∞
| 56.39K |
$2.66 | $149,997.40 | 56.39K |
Nov 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
aTYR PHARMA INC (LIFE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +833.33% | 50K |
$1.75 | $87,500.00 | 56K |
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
| 6K |
May 17
| |||
Form 4
|
∞
| 6K |
—
|
—
| 6K |
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||